| Dr Tigist Girmy Mehari, MD | |
|
17198 St Lukes Way Ste 600, The Woodlands, TX 77384-8017 | |
| (934) 266-2450 | |
| Not Available |
| Full Name | Dr Tigist Girmy Mehari |
|---|---|
| Gender | Female |
| Speciality | Neurology |
| Experience | 12 Years |
| Location | 17198 St Lukes Way Ste 600, The Woodlands, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235490426 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Luke's The Woodlands Hospital | The woodlands, TX | Hospital |
| Chi St Lukes Lakeside Hospital | The woodlands, TX | Hospital |
| Chi St Luke's Health Baylor College Of Medicine Me | Houston, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baylor St Lukes Medical Group | 9133213192 | 169 |
News Archive
EpiCept Corporation today announced that at a recent meeting with the U.S. Food and Drug Administration (FDA) the Company was provided more definitive guidance regarding the clinical development of Ceplene, the Company's lead product administered with interleukin-2 (IL-2) for the remission maintenance and prevention of relapse of patients with acute myeloid leukemia (AML) in first complete remission.
A project to promote self-management for people living with kidney failure is being developed by researchers at the University of Hertfordshire at the Lister Hospital.
aTyr Pharma, Inc., a biopharmaceutical company discovering and developing a new class of naturally occurring proteins as biotherapeutics, will present at the BioPartnering Europe Conference in London on Monday October 12. Jeff Watkins, CEO of aTyr Pharma, will provide an overview of aTyr Pharma's technology, product engine, and lead program based on naturally occurring resected proteins of the tRNA synthetases.
University of Utah Medical Group (UUMG), a multispecialty academic medical group practice has selected Practical Data Solutions (PDS) to migrate their data warehouse and analytical reporting to the EPIC system which is scheduled to go live November 1st of this year.
On June 28 and 29, academic thought leaders and high-ranking officers from pharma, biotech and information technology companies will gather in Paris at the 4th WIN Symposium to present and discuss breakthroughs that will bring personalized cancer medicine to the next phase.
› Verified 3 days ago
| Entity Name | Baylor St Lukes Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740485879 PECOS PAC ID: 9133213192 Enrollment ID: O20070920000863 |
News Archive
EpiCept Corporation today announced that at a recent meeting with the U.S. Food and Drug Administration (FDA) the Company was provided more definitive guidance regarding the clinical development of Ceplene, the Company's lead product administered with interleukin-2 (IL-2) for the remission maintenance and prevention of relapse of patients with acute myeloid leukemia (AML) in first complete remission.
A project to promote self-management for people living with kidney failure is being developed by researchers at the University of Hertfordshire at the Lister Hospital.
aTyr Pharma, Inc., a biopharmaceutical company discovering and developing a new class of naturally occurring proteins as biotherapeutics, will present at the BioPartnering Europe Conference in London on Monday October 12. Jeff Watkins, CEO of aTyr Pharma, will provide an overview of aTyr Pharma's technology, product engine, and lead program based on naturally occurring resected proteins of the tRNA synthetases.
University of Utah Medical Group (UUMG), a multispecialty academic medical group practice has selected Practical Data Solutions (PDS) to migrate their data warehouse and analytical reporting to the EPIC system which is scheduled to go live November 1st of this year.
On June 28 and 29, academic thought leaders and high-ranking officers from pharma, biotech and information technology companies will gather in Paris at the 4th WIN Symposium to present and discuss breakthroughs that will bring personalized cancer medicine to the next phase.
› Verified 3 days ago
| Entity Name | Hospital Docs Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871792309 PECOS PAC ID: 7517052822 Enrollment ID: O20071002000420 |
News Archive
EpiCept Corporation today announced that at a recent meeting with the U.S. Food and Drug Administration (FDA) the Company was provided more definitive guidance regarding the clinical development of Ceplene, the Company's lead product administered with interleukin-2 (IL-2) for the remission maintenance and prevention of relapse of patients with acute myeloid leukemia (AML) in first complete remission.
A project to promote self-management for people living with kidney failure is being developed by researchers at the University of Hertfordshire at the Lister Hospital.
aTyr Pharma, Inc., a biopharmaceutical company discovering and developing a new class of naturally occurring proteins as biotherapeutics, will present at the BioPartnering Europe Conference in London on Monday October 12. Jeff Watkins, CEO of aTyr Pharma, will provide an overview of aTyr Pharma's technology, product engine, and lead program based on naturally occurring resected proteins of the tRNA synthetases.
University of Utah Medical Group (UUMG), a multispecialty academic medical group practice has selected Practical Data Solutions (PDS) to migrate their data warehouse and analytical reporting to the EPIC system which is scheduled to go live November 1st of this year.
On June 28 and 29, academic thought leaders and high-ranking officers from pharma, biotech and information technology companies will gather in Paris at the 4th WIN Symposium to present and discuss breakthroughs that will bring personalized cancer medicine to the next phase.
› Verified 3 days ago
| Entity Name | Virtual Neurology Texas Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467092114 PECOS PAC ID: 3779910047 Enrollment ID: O20200226001130 |
News Archive
EpiCept Corporation today announced that at a recent meeting with the U.S. Food and Drug Administration (FDA) the Company was provided more definitive guidance regarding the clinical development of Ceplene, the Company's lead product administered with interleukin-2 (IL-2) for the remission maintenance and prevention of relapse of patients with acute myeloid leukemia (AML) in first complete remission.
A project to promote self-management for people living with kidney failure is being developed by researchers at the University of Hertfordshire at the Lister Hospital.
aTyr Pharma, Inc., a biopharmaceutical company discovering and developing a new class of naturally occurring proteins as biotherapeutics, will present at the BioPartnering Europe Conference in London on Monday October 12. Jeff Watkins, CEO of aTyr Pharma, will provide an overview of aTyr Pharma's technology, product engine, and lead program based on naturally occurring resected proteins of the tRNA synthetases.
University of Utah Medical Group (UUMG), a multispecialty academic medical group practice has selected Practical Data Solutions (PDS) to migrate their data warehouse and analytical reporting to the EPIC system which is scheduled to go live November 1st of this year.
On June 28 and 29, academic thought leaders and high-ranking officers from pharma, biotech and information technology companies will gather in Paris at the 4th WIN Symposium to present and discuss breakthroughs that will bring personalized cancer medicine to the next phase.
› Verified 3 days ago
| Entity Name | Tigist Mehari Md Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578234563 PECOS PAC ID: 4789082363 Enrollment ID: O20211012002900 |
News Archive
EpiCept Corporation today announced that at a recent meeting with the U.S. Food and Drug Administration (FDA) the Company was provided more definitive guidance regarding the clinical development of Ceplene, the Company's lead product administered with interleukin-2 (IL-2) for the remission maintenance and prevention of relapse of patients with acute myeloid leukemia (AML) in first complete remission.
A project to promote self-management for people living with kidney failure is being developed by researchers at the University of Hertfordshire at the Lister Hospital.
aTyr Pharma, Inc., a biopharmaceutical company discovering and developing a new class of naturally occurring proteins as biotherapeutics, will present at the BioPartnering Europe Conference in London on Monday October 12. Jeff Watkins, CEO of aTyr Pharma, will provide an overview of aTyr Pharma's technology, product engine, and lead program based on naturally occurring resected proteins of the tRNA synthetases.
University of Utah Medical Group (UUMG), a multispecialty academic medical group practice has selected Practical Data Solutions (PDS) to migrate their data warehouse and analytical reporting to the EPIC system which is scheduled to go live November 1st of this year.
On June 28 and 29, academic thought leaders and high-ranking officers from pharma, biotech and information technology companies will gather in Paris at the 4th WIN Symposium to present and discuss breakthroughs that will bring personalized cancer medicine to the next phase.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Tigist Girmy Mehari, MD 17198 St Lukes Way, The Woodlands, TX 77384-8011 Ph: () - | Dr Tigist Girmy Mehari, MD 17198 St Lukes Way Ste 600, The Woodlands, TX 77384-8017 Ph: (934) 266-2450 |
News Archive
EpiCept Corporation today announced that at a recent meeting with the U.S. Food and Drug Administration (FDA) the Company was provided more definitive guidance regarding the clinical development of Ceplene, the Company's lead product administered with interleukin-2 (IL-2) for the remission maintenance and prevention of relapse of patients with acute myeloid leukemia (AML) in first complete remission.
A project to promote self-management for people living with kidney failure is being developed by researchers at the University of Hertfordshire at the Lister Hospital.
aTyr Pharma, Inc., a biopharmaceutical company discovering and developing a new class of naturally occurring proteins as biotherapeutics, will present at the BioPartnering Europe Conference in London on Monday October 12. Jeff Watkins, CEO of aTyr Pharma, will provide an overview of aTyr Pharma's technology, product engine, and lead program based on naturally occurring resected proteins of the tRNA synthetases.
University of Utah Medical Group (UUMG), a multispecialty academic medical group practice has selected Practical Data Solutions (PDS) to migrate their data warehouse and analytical reporting to the EPIC system which is scheduled to go live November 1st of this year.
On June 28 and 29, academic thought leaders and high-ranking officers from pharma, biotech and information technology companies will gather in Paris at the 4th WIN Symposium to present and discuss breakthroughs that will bring personalized cancer medicine to the next phase.
› Verified 3 days ago
Dr. Arshad Ahmed, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 17200 St Lukes Way, The Woodlands, TX 77384 Phone: 936-266-2000 | |
Dr. Lourdes Ramirez Bosquez, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 9006 Forest Xing, Suite C, The Woodlands, TX 77381 Phone: 281-364-9884 Fax: 281-364-7747 | |
Dr. Stuart Andrew Leder, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 9200 New Trails Dr, Suite 100a, The Woodlands, TX 77381 Phone: 281-364-9509 Fax: 281-364-0984 | |
Dan-vy Mui, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 9595 Six Pines Dr Ste 8210, The Woodlands, TX 77380 Phone: 832-631-6051 Fax: 832-631-6256 | |
Deanne Lolita Degreaffenreidte, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 17200 St Lukes Way, The Woodlands, TX 77384 Phone: 281-942-8001 Fax: 281-724-1919 | |
Dr. Linh Dang, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 17183 I-45 South, Suite 590, The Woodlands, TX 77385 Phone: 936-760-2230 Fax: 936-760-2239 | |
Dr. Ryan O'neill Mcdonald, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 9303 Pinecroft Dr, Suite 270, The Woodlands, TX 77380 Phone: 281-465-4050 Fax: 281-465-4105 |